LeJeune Puetz Investment Counsel’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

LeJeune Puetz Investment Counsel’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,200	Closed	-$110K	–	193
2022 Q2	$110K	Hold	2,200	–	–	0.04%	188
2022 Q1	$112K	Sell	2,200 -1,400	-39%	-$7.87K	0.04%	187
2021 Q4	$219K	Sell	3,600 -600	-14%	-$2.6K	0.07%	148
2021 Q3	$202K	Hold	4,200	–	–	0.07%	150
2021 Q2	$221K	Hold	4,200	–	–	0.08%	148
2021 Q1	$208K	Hold	4,200	–	–	0.08%	150
2020 Q4	$204K	Hold	4,200	–	–	0.09%	145
2020 Q3	$211K	Hold	4,200	–	–	0.1%	133
2020 Q2	$214K	Hold	4,200	–	–	0.11%	129
2020 Q1	$184K	Hold	4,200	–	–	0.11%	134
2019 Q4	$211K	Hold	4,200	–	–	0.1%	143
2019 Q3	$195K	Sell	4,200 -1,138	-21%	-$5.69K	0.1%	142
2019 Q2	$182K	Hold	5,338	–	–	0.09%	144
2019 Q1	$186K	Hold	5,338	–	–	0.1%	140
2018 Q4	$182K	Hold	5,338	–	–	0.11%	130
2018 Q3	$188K	Hold	5,338	–	–	0.11%	133
2018 Q2	$168K	Hold	5,338	–	–	0.1%	138
2018 Q1	$168K	Hold	5,338	–	–	0.1%	127
2017 Q4	$181K	Sell	5,338 -97	-2%	-$904	0.11%	124
2017 Q3	$213K	Buy	5,435 +4,930	+976%	+$51.8K	0.14%	118
2017 Q2	$190K	Hold	505	–	–	0.13%	122
2017 Q1	$180K	Hold	505	–	–	0.13%	121
2016 Q4	$161K	Buy	+505	New	+$21.5K	0.12%	122

Other funds holding MACK

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $295M AUM 40.98% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $1.99B AUM 22.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WIM

Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

LeJeune Puetz Investment Counsel's MACK Position: Q3 2022 in Review

LeJeune Puetz Investment Counsel sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q3 2022, closing a stake of 2,200 shares — an estimated $110K sold.

LeJeune Puetz Investment Counsel first reported a position in MACK in Q4 2016 and held it in 23 quarters. The position peaked at $221K in Q2 2021. 41 funds tracked by Wall St. Rank hold MACK as of Q3 2022.

LeJeune Puetz Investment Counsel reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
LeJeune Puetz Investment Counsel sold 2,200 Merrimack Pharmaceuticals, Inc. shares in Q3 2022, an estimated $110K.
LeJeune Puetz Investment Counsel first reported a position in Merrimack Pharmaceuticals, Inc. in Q4 2016 and held it in 23 quarters.
LeJeune Puetz Investment Counsel's Merrimack Pharmaceuticals, Inc. position peaked at $221K in Q2 2021.
41 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q3 2022.

Based on LeJeune Puetz Investment Counsel's 13F filing for Q3 2022, filed 8 Nov 2022.